In a recent significant development set to change the healthcare landscape, Germfree and Orgenesis Inc. have joined forces. This strategic partnership establishes a noble ambition: to revolutionize the production of much-needed cell and gene therapies. The aim is clear—to enhance the availability
In a bold move to expand its immunology portfolio, Johnson & Johnson has announced the acquisition of Proteologix, Inc. for an $850 million upfront payment, with additional milestone payments on the horizon. This strategic purchase positions Johnson & Johnson at the forefront of biotechnological
As we progress into the 2020s, the pharmaceutical industry is steered toward an era of both exciting potential and challenges. The year 2024 is poised to be pivotal, influenced by a complex mix of factors including rigorous regulation, technological advancements, demand for sustainability, and the
The utilization of artificial intelligence (AI) is transforming the pharmaceutical industry, infusing manufacturing practices with unprecedented efficiency and innovation. However, this surge of technological advancement beckons a new era of regulation, presenting unique challenges for
The pharmaceutical industry is on the verge of a transformative period with technology leading the way in revolutionizing its manufacturing processes. In the near future, we anticipate groundbreaking innovations that will significantly alter the landscape of pharma production. However, along with
